Skip to main content
XTIA logo
XTIA
(NASDAQ)
XTI Aerospace, Inc.
$2.00-- (--)
Loading... - Market loading

XTI Aerospace (XTIA) Income Statement

Revenue, expenses, profit margins, and earnings with annual and quarterly data.

XTI Aerospace Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scroll to see more
XTI Aerospace, Inc. income statement - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Revenue & Gross Profit
Revenue3.204.566.1116.009.306.303.763.94
Cost of Revenue1.312.302.124.376.246.765.866.03
Gross Profit1.892.263.997.153.06-0.46-2.11-2.09
Operating Expenses
Research & Development4.001.384.482.676.520.251.230.96
Selling, General & Administrative25.254.3416.2714.6321.643.3614.3211.38
Operating Expenses29.875.7413.9917.3028.173.6115.5512.35
Operating Income-27.98-5.74-13.99-17.30-25.11-3.61-17.66-14.44
Other Income/Expense
Interest Income0.360.000.001.180.000.301.240.00
Interest Expense-1.16-1.23-0.880.692.43-0.301.241.88
Other Income/Expense-0.26-0.270.01-0.40-4.16-4.41-2.13-3.64
Income
Income Before Tax-35.59-25.07-19.86-18.45-29.27-3.91-19.78-18.08
Income Tax Expense0.020.02-0.18-1.41-0.06-0.580.000.00
Net Income-35.60-25.07-0.47-18.45-29.23-3.91-24.57-35.01
Net Income - Continuous Operations-35.60-45.95-19.68-18.45-29.23-33.99-24.57-35.01
Net Income - Discontinued Operations0.00-12.75-46.620.000.000.000.000.00
EBITDA-36.01-7.55-11.08-17.73-23.22-3.60-13.76-11.40
EBIT-36.98-7.59-19.24-17.76-23.79-3.610.000.00
Depreciation & Amortization0.740.040.040.033.620.014.794.80
Earnings Per Share
Basic EPS-6.00-1576.00-853022.00-7674.00-7612.00-27.00-25.00-21.00
Diluted EPS-163.00-1576.00-3.00-7674.00-7612.00-27.00-25.00-21.00
Basic Shares Outstanding6.750.020.000.000.040.150.150.15
Diluted Shares Outstanding6.750.020.000.000.040.150.150.15

These financial metrics are calculated using income statement data. Learn how each metric works and screen stocks by them.